Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | EW | TMO |
|---|
| Close | 92.01 | 697.00 |
| Market Cap | $53.6B | $258B |
| 1M | +6.59% | +3.25% |
| P/E (TTM) | 53.7 | 36.4 |
| Forward P/E | 31.0 | 24.6 |
| P/E 5-Yr Percentile | 100 | 78 |
| P/S | 8.3 | 5.4 |
| P/B | 5.1 | 4.7 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $1.7B | $12.1B |
| Revenue YoY | +13.6% | +9.1% |
| Gross Margin | 77.5% | — |
| Latest Quarter EPS | 0.42 | 4.64 |
| Avg Post-Earnings Move | ±3.9% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | 2 / 2 | — |
| Shareholder Yield | 2.25% | 1.82% |
| 90-Day Net Insider Buying | −$3.5M | −$40.3M |
EW · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
